Literature DB >> 23828148

Monitoring treatment adherence in hypertension.

Serap Erdine1, Eren Arslan.   

Abstract

Hypertension is associated with high mortality and morbidity that will increase if hypertension is left untreated. Treatment adherence is crucial in blood pressure control, and monitoring patient adherence is essential to the successful management of hypertension, since nonadherence is associated with poor prognosis. There are both direct and indirect methods to monitor adherence. Direct methods can be defined as assessment of treatment response or level of drug or its metabolite in blood, urine and body fluids without any intermediate or agent. Indirect methods require several instruments, such as questionnaires, reports, devices, and monitors. Certain methods may be advantageous in specific clinical and research settings. Advances in technology (new tools, devices, laboratory methods), and new approaches to reporting will not only help patients control high blood pressure but decrease hypertension-related mortality and morbidity.

Entities:  

Mesh:

Year:  2013        PMID: 23828148     DOI: 10.1007/s11906-013-0369-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  18 in total

1.  Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy.

Authors:  Adedokun Ayoade; Idris Oladipo
Journal:  Blood Press       Date:  2012-04-18       Impact factor: 2.835

2.  Electronic monitoring of adherence, treatment of hypertension, and blood pressure control.

Authors:  Hein A W van Onzenoort; Willem J Verberk; Abraham A Kroon; Alfons G H Kessels; Cees Neef; Paul-Hugo M van der Kuy; Peter W de Leeuw
Journal:  Am J Hypertens       Date:  2011-10-13       Impact factor: 2.689

Review 3.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

4.  Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Authors:  Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

5.  Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study.

Authors:  Péter Doró; Ria Benko; Anikó Czakó; Mária Matuz; Ferenc Thurzó; Gyöngyvér Soós
Journal:  Int J Clin Pharm       Date:  2011-06-21

Review 6.  Selection of a validated scale for measuring medication adherence.

Authors:  Stacey M Lavsa; Ashley Holzworth; Nicole T Ansani
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Jan-Feb

7.  The 'cost' of medication nonadherence: consequences we cannot afford to accept.

Authors:  Marie A Chisholm-Burns; Christina A Spivey
Journal:  J Am Pharm Assoc (2003)       Date:  2012

8.  When drugs don't work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices.

Authors:  Dyfrig Hughes
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 9.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

10.  Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults.

Authors:  Virginie Korb-Savoldelli; Florence Gillaizeau; Jacques Pouchot; Emilie Lenain; Nicolas Postel-Vinay; Pierre-François Plouin; Pierre Durieux; Brigitte Sabatier
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04-26       Impact factor: 3.738

View more
  6 in total

1.  Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.

Authors:  Jeffrey J Weiss; Ioannis Konstantinidis; Anna Boueilh; Daniel S Fierer; Donald Gardenier; Mark G Barber; Tony Kang; Anna Kress; Katherine Ericson; Marlene C Lira; Marina P Yostos; Hillary R Bogner; Juan P Wisnivesky; Christina M Wyatt
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

Review 2.  Blood pressure outcomes of medication adherence interventions: systematic review and meta-analysis.

Authors:  Vicki S Conn; Todd M Ruppar; Jo-Ana D Chase
Journal:  J Behav Med       Date:  2016-03-11

Review 3.  Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis.

Authors:  Vicki S Conn; Todd M Ruppar; Jo-Ana D Chase; Maithe Enriquez; Pamela S Cooper
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

4.  Family member-based supervision of patients with hypertension: a cluster randomized trial in rural China.

Authors:  Y Shen; X Peng; M Wang; X Zheng; G Xu; L Lü; K Xu; B Burstrom; K Burstrom; J Wang
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

5.  Relationship Between Adherence to Remote Monitoring and Patient Characteristics: Observational Study in Women With Pregnancy-Induced Hypertension.

Authors:  Thijs Vandenberk; Dorien Lanssens; Valerie Storms; Inge M Thijs; Lotte Bamelis; Lars Grieten; Wilfried Gyselaers; Eileen Tang; Patrick Luyten
Journal:  JMIR Mhealth Uhealth       Date:  2019-08-28       Impact factor: 4.773

6.  A clinical trial on the effect of a multifaceted intervention on blood pressure control and medication adherence in patients with uncontrolled hypertension.

Authors:  Azam-Alsadat Mirniam; Zahra Habibi; Alireza Khosravi; Masoumeh Sadeghi; Maryam Eghbali-Babadi
Journal:  ARYA Atheroscler       Date:  2019-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.